SUBSCRIBE

Breaking News on Global Pharmaceutical Technology & Manufacturing

GSK in Talks with Several Firms for Romanian Oral Dose Plant

05-Sep-2013 - GlaxoSmithKline is in talks with a number of companies interested in buying its Romanian manufacturing facility that was recently earmarked for closure.

Chiron and Panacea End Injectables JV Amicably, Says Novartis

02-Sep-2013 - Novartis-owned Chiron and Panacea Biotec have amicably dissolved their vaccine joint venture due to strategic regions, according to Novartis.

update

CordenPharma Owner Buys Belgian Peptide Firm to Boost API business

29-Aug-2013 - ICIG will buy the Belgian operation of peptide maker Peptisyntha SA from Solvay to expand its recently rejigged contract API business.

Who's Bought Who in the Late Summer Sales

28-Aug-2013 - Amgen spent $10.4bn (€7.8bn) this week on Onyx Pharmaceuticals, but AstraZeneca and Johnson & Johnson have also opened up their wallets this week – welcome to in-Pharmatechnologist.com’s merger & acquisition...

News in brief

Amgen Acquires Onyx for $10.4bn

26-Aug-2013 - Amgen has spent $10.4bn (€7.8bn) in acquiring Onyx Pharmaceuticals saying its oncology products and pipeline will be strengthened by Amgen’s manufacturing capabilities.

Fresenius to Establish Indonesian Manufacturing Hub in 51% Acq

20-Aug-2013 - Fresenius Kabi will focus on intravenous generics and infusion solutions as it acquires a 51 percent stake in an Indonesian pharma company.

Spin Off OTC Unit in Pharmstandard's Vision as it Buys API Supplier

14-Aug-2013 - Pharmstandard says the acquisition of Bever Pharmaceuticals will lower the cost of its API supply as it plans to spin out an OTC business.

Aurobindo Focuses on Injectables with Plans for Spin-Off Subsidiary

13-Aug-2013 - Consolidating its Indian injectable business under a new subsidiary will improve focus and align quality control, says Aurobindo who has invested in two manufacturing companies to support such plans.

Excipients Boost Efficacy in Oral Delivery Platform, says Enteris

06-Aug-2013 - Enteris has acquired an oral drug delivery platform from Unigene Laboratories and says the excipients used can increase solubility and absorption for both peptides and small molecules.

Merck & Co to Halt Production at NJ Plant and Focus on Biologics R&D

06-Aug-2013 - Merck & Co. will close the doors on its Kenilworth, New Jersey manufacturing plant affecting 100 jobs in a continuation of its consolidation efforts.

Kemwell Acquires US Delivery Development Firm

05-Aug-2013 - Kemwell has positioned a foothold in the US with the acquisition of drug delivery research firm Cirrus Pharmaceuticals.

News in brief

Medicines and Vaccines Merge to Form Single NZ Body

31-Jul-2013 - Medicines New Zealand has merged with the Vaccines Industry Association of New Zealand (VIANZ) in order to share resources and provide a single point of contact for all stakeholders.

2,700 Jobs Could Go as Valeant Integrates B+L Acquisition

30-Jul-2013 - Valeant says it will slash its workforce by up to 15% and consolidate some of its non-US locations following the acquisition of Bausch & Lomb.

Drug Pack Leak Test Firm Sepha Bought By Tasi

25-Jul-2013 - Tasi Group has acquired pharmaceutical leak testing firm Sepha and plans to seek more customers overseas.

Teva Doubles Production as Japanese Change Attitude to Generics

09-Jul-2013 - Teva says it will reap the benefits of changing attitudes to generic drugs in Japan as it doubles its production capacity in the country.

MicroDose of Fresh Air for Teva with Respiratory Acquisition

18-Jun-2013 - Teva has affirmed its respiratory drug delivery strategy with the purchase of MicroDose Therapeutx for a potential $165m (€123m).

News in brief

Sun Pharma Looking to Grow but Meda Denies Takeover Discussions

05-Jun-2013 - Swedish allergy drug company Meda has denied it has been in discussions with Sun Pharma over a possible $5bn (€3.8bn) takeover.

GSK's €250m Acquisition Brings T-Cell Vaccine Tech In-House

30-May-2013 - GlaxoSmithKline has brought its vaccine development in-house with the purchase of Okairos and its supplementary technology platform.

BMS to Shutter Ex-Amylin Facility - Redundancies Inevitable

09-Apr-2013 - Bristol-Myers Squibb says shuttering Amylin’s San Diego facilities will accelerate its diabetes R&D joint venture with AstraZeneca though approximately 300 jobs will be lost.

AmerisourceBergen Exits Contract Packaging and Canadian Distribution

03-Apr-2013 - AmerisourceBergen has sold AndersonBrecon for $308m, exiting the contract packaging business in order to concentrate on its core business.

Shire's Vision Strengthened with $160m Acquisition

26-Mar-2013 - Shire says it is laying down a foundation into the specialty ophthalmology field following its second acquisition in a matter of weeks.

AB Technology Buys Angel's Edinburgh Assets

19-Mar-2013 - As the dissolution of Angel continues, its core manufacturing facility has been bought by AB Technology ensuring long term operations and rescuing 23 jobs.

Fallen Angel Sells Collagen Supply Wing to Collbio

18-Mar-2013 - Following last week’s shuttering of a manufacturing plant administrators have sold Angel Biomedical to new company Collbio as they start offloading CMOs assets.

Shire Snaps Up Swedish Infant Blindness Drug Developer

14-Mar-2013 - Shire has entered the neonatology market by acquiring Premacure and a new therapy and delivery technology designed to treat infant blindness.

Actavis Shutters Unit Following Watson Takeover R&D Double-Up

14-Mar-2013 - Following an analysis of its global R&D business Actavis says it will close its Maltese R&D unit at a cost of 60 jobs.

Key Industry Events

 

Access all events listing

Our events, Events from partners...

Products

Solid Lipid Excipients: Born to be Extruded !
Gattefossé Pharma
USP<233> Elemental Impurities Sample Prep Strategy
SGS Life Science Services
Online Cell Density Monitoring
Hamilton Bonaduz AG
Residual moisture in lyophilized pharmaceuticals
Metrohm – customized analysis for the pharmaceutical industry
Need help to bring insoluble APIs to the market?
Dow Pharma & Food Solutions